Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
about
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexesUsefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic reviewMannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interactionSLURP-1 modulates corneal homeostasis by serving as a soluble scavenger of urokinase-type plasminogen activatorNeutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient miceMyosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells.A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastaseSerum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.SPRY1 promotes the degradation of uPAR and inhibits uPAR-mediated cell adhesion and proliferationCathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in gliomaUrokinase type plasminogen activator receptor expression in colorectal neoplasms.Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma.The urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system.Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort studyStructural basis of interaction between urokinase-type plasminogen activator and its receptorReceptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth.Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.SH2B1beta (SH2-Bbeta) enhances expression of a subset of nerve growth factor-regulated genes important for neuronal differentiation including genes encoding urokinase plasminogen activator receptor and matrix metalloproteinase 3/10.Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes.Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malariaTransforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptorRole of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitroMechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element.CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion.Formation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor.Role of formic receptors in soluble urokinase receptor-induced human vascular smooth muscle migration.siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
P2860
Q24532196-DB72BF1F-7631-4893-B1EA-D3D9DBC0AAA2Q24614787-A10C4465-F994-425A-AF4B-460CBF41F195Q24683196-8A2A5666-4702-48BC-A49A-E9EFD83BEF6BQ28115141-37519E25-B4E9-415A-A0F1-FC683FE010EAQ28749280-77A03B62-133D-42A9-861E-A36F1CC9FE13Q30304130-AD2E67F5-916A-4AE6-8C9B-81F7CF4F52B0Q30307084-7B924BCB-7E86-448D-987B-A0436E50D706Q30486721-CE2C81C1-088A-4E12-8D9F-521B1ED94888Q33887878-F0BF98F2-69AC-4C33-8525-E73E51533DEBQ34009345-EC97E94E-DD04-4696-92CE-C28D8EA3E120Q34330943-6E7FEA86-B731-494E-AFFD-BEF5453D66F5Q34370103-987BE326-6262-4B35-8DC6-445C5FC74537Q34489359-6BE63DE4-25FB-4E65-9758-360800FB8719Q34704836-80D0C36B-BCEE-415B-8DC7-AAD451037C75Q34987834-BE545014-A717-4B01-A032-7701D9BEACB9Q35353534-EB952D1D-EF39-4834-9150-8B2168718115Q35721585-C9494E24-B5C1-4D80-9D42-0EA23DD2F8A4Q35753150-246D4EE2-D768-4FB5-B056-E2CBCCDED49AQ35789112-AE8FED5F-D834-4F1F-8E4C-BA02472DF92EQ36046670-9F7E2B86-AEB5-43AE-B3A3-9D376911A282Q36073215-A405FB35-F79E-4C63-94C0-B09360A3E57AQ36237711-6B9B42F6-8273-4800-A2F5-673C3A96B51AQ36254926-B0305CA8-6668-40AC-8DFF-72000AD9E43CQ36324730-5BFF81A6-7EEA-47B6-B172-C84394BA51E4Q36401755-44835242-BAC9-49D7-B3A0-DC07E291DAB3Q36447422-F122EE39-268C-49AF-A3AD-18B0BF549296Q36619635-A6B709EE-8025-48E4-8C0F-BF81435A0E26Q37271801-CF81A29C-07E3-4A6E-B1A8-BA7E666D8590Q37359182-40A231D0-F05D-4C00-AFB5-13A13F2CF9CEQ37380155-7897921B-6A08-40E1-87DC-114F7AA1ED5CQ37716666-11007837-7BAD-43D3-A9C3-D479856996A0Q38132176-1DC7A4E5-BAAF-43A0-9506-40ED43860CD5Q38164339-55E4394C-1132-4A15-87D3-28F2167896DAQ38311280-D9B1012A-7878-47C1-A290-9B9DF09E271DQ39246016-BD614E08-5739-4EAB-A0AB-CAE6F599A204Q39575499-66B5B51F-AC22-4671-8EE6-AD66E11DEE3AQ39726296-C533B327-FE30-4D58-9291-C1B6D767A0C4Q40012120-0FA105C8-6B0D-4E1B-876B-15A150A41152Q40186402-A397FD8A-064E-42FF-A860-58E0888A664DQ40307294-679787FA-EC74-432D-A56B-8A5EDA302882
P2860
Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Proteolytic cleavage of the ur ...... ist-induced chemotactic effect
@en
type
label
Proteolytic cleavage of the ur ...... ist-induced chemotactic effect
@en
prefLabel
Proteolytic cleavage of the ur ...... ist-induced chemotactic effect
@en
P2093
P2860
P1433
P1476
Proteolytic cleavage of the ur ...... ist-induced chemotactic effect
@en
P2093
Guttinger M
Valcamonica S
P2860
P304
P356
10.1002/J.1460-2075.1996.TB00502.X
P407
P577
1996-04-01T00:00:00Z